{"entity":{"type":"insider","cik":"0001435388","url":"/insider/0001435388","json_url":"/insider/0001435388.json","name":"Clark B. Jefferson","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":10,"first":"2013-02-26","last":"2015-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Clark B. Jefferson","source":"filing","n_filings":10,"first_seen":"2013-02-26","last_seen":"2015-05-13"}],"transactions":[{"id":8386903,"accession":"0001578563-15-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-15-000013","line_url":"/filing/0001578563-15-000013#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":13500.0,"total_display":"13,500.00","total_whole":"13,500","shares_owned_after":13139215.0,"shares_owned_after_display":"13,139,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-13","scope":"insider"},{"id":8762388,"accession":"0001578563-15-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-15-000004","line_url":"/filing/0001578563-15-000004#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Aldagen Holdings, LLC; Brooke William W","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":1925.0,"total_display":"1,925.00","total_whole":"1,925","shares_owned_after":12181395.0,"shares_owned_after_display":"12,181,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-22","scope":"insider"},{"id":8806140,"accession":"0001578563-15-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-15-000003","line_url":"/filing/0001578563-15-000003#line-2","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Brooke William W; Aldagen Holdings, LLC","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153467.0,"shares_display":"153,467","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":53713.45,"total_display":"53,713.45","total_whole":"53,713","shares_owned_after":12186895.0,"shares_owned_after_display":"12,186,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-14","filed_date":"2015-01-15","scope":"insider"},{"id":8806139,"accession":"0001578563-15-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-15-000003","line_url":"/filing/0001578563-15-000003#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Brooke William W; Aldagen Holdings, LLC","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":4900.0,"total_display":"4,900.00","total_whole":"4,900","shares_owned_after":12340362.0,"shares_owned_after_display":"12,340,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-13","filed_date":"2015-01-15","scope":"insider"},{"id":8777647,"accession":"0001578563-15-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578563-15-000002","line_url":"/filing/0001578563-15-000002#line-3","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73496.0,"shares_display":"73,496","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":25723.6,"total_display":"25,723.60","total_whole":"25,724","shares_owned_after":12354362.0,"shares_owned_after_display":"12,354,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-12","scope":"insider"},{"id":8777646,"accession":"0001578563-15-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-15-000002","line_url":"/filing/0001578563-15-000002#line-2","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61037.0,"shares_display":"61,037","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":21362.95,"total_display":"21,362.95","total_whole":"21,363","shares_owned_after":12427858.0,"shares_owned_after_display":"12,427,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-12","scope":"insider"},{"id":8472898,"accession":"0001578563-15-000012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001578563-15-000012","line_url":"/filing/0001578563-15-000012#line-4","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15850.0,"shares_display":"15,850","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":5547.5,"total_display":"5,547.50","total_whole":"5,548","shares_owned_after":13189215.0,"shares_owned_after_display":"13,189,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-03-12","scope":"insider"},{"id":8777645,"accession":"0001578563-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-15-000002","line_url":"/filing/0001578563-15-000002#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82850.0,"shares_display":"82,850","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":28997.5,"total_display":"28,997.50","total_whole":"28,998","shares_owned_after":12488895.0,"shares_owned_after_display":"12,488,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":8112856,"accession":"0001578563-15-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-15-000001","line_url":"/filing/0001578563-15-000001#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Brooke William W; Aldagen Holdings, LLC; Clark B. Jefferson","owner_display_name":"Brooke William W","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":35.0,"total_display":"35.00","total_whole":"35","shares_owned_after":12571745.0,"shares_owned_after_display":"12,571,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-31","filed_date":"2015-01-02","scope":"insider"},{"id":8472894,"accession":"0001578563-15-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578563-15-000012","line_url":"/filing/0001578563-15-000012#line-3","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":420.0,"total_display":"420.00","total_whole":"420","shares_owned_after":13205065.0,"shares_owned_after_display":"13,205,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2015-03-12","scope":"insider"},{"id":6590034,"accession":"0001578563-14-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-14-000004","line_url":"/filing/0001578563-14-000004#line-2","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Brooke William W; Aldagen Holdings, LLC; Clark B. Jefferson","owner_display_name":"Brooke William W","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299900.0,"shares_display":"299,900","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":104965.0,"total_display":"104,965.00","total_whole":"104,965","shares_owned_after":12571845.0,"shares_owned_after_display":"12,571,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2014-12-31","scope":"insider"},{"id":6590032,"accession":"0001578563-14-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-14-000004","line_url":"/filing/0001578563-14-000004#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc.","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Brooke William W; Aldagen Holdings, LLC; Clark B. Jefferson","owner_display_name":"Brooke William W","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":35.0,"total_display":"35.00","total_whole":"35","shares_owned_after":12871745.0,"shares_owned_after_display":"12,871,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-29","filed_date":"2014-12-31","scope":"insider"},{"id":6881011,"accession":"0001578563-14-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001578563-14-000003","line_url":"/filing/0001578563-14-000003#line-3","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Aldagen Holdings, LLC; Brooke William W","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10300.0,"shares_display":"10,300","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":3811.0,"total_display":"3,811.00","total_whole":"3,811","shares_owned_after":12871845.0,"shares_owned_after_display":"12,871,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-23","scope":"insider"},{"id":6881007,"accession":"0001578563-14-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-14-000003","line_url":"/filing/0001578563-14-000003#line-2","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Aldagen Holdings, LLC; Brooke William W","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97150.0,"shares_display":"97,150","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":34002.5,"total_display":"34,002.50","total_whole":"34,003","shares_owned_after":12882145.0,"shares_owned_after_display":"12,882,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2014-12-23","scope":"insider"},{"id":6880998,"accession":"0001578563-14-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-14-000003","line_url":"/filing/0001578563-14-000003#line-1","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"Nuo Therapeutics, Inc","issuer_ticker":"NUOT","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Clark B. Jefferson; Aldagen Holdings, LLC; Brooke William W","owner_display_name":"Clark B. Jefferson","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":997.5,"total_display":"997.50","total_whole":"998","shares_owned_after":12979295.0,"shares_owned_after_display":"12,979,295","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-28","filed_date":"2014-12-23","scope":"insider"},{"id":5058907,"accession":"0001140361-13-034586","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-13-034586","line_url":"/filing/0001140361-13-034586#line-6","is_derivative":false,"issuer_cik":"0001311596","issuer_name":"Regado Biosciences Inc","issuer_ticker":"RGDO","issuer_name_source":null,"issuer_url":"/issuer/0001311596","owner_cik":"0001435388","owner_name":"Clark B. Jefferson","owner_display_name":"Clark B. Jefferson","owner_url":"/insider/0001435388","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":359310.0,"shares_display":"359,310","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1437240.0,"total_display":"1,437,240.00","total_whole":"1,437,240","shares_owned_after":1114759.0,"shares_owned_after_display":"1,114,759","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-27","filed_date":"2013-08-29","scope":"insider"},{"id":4998594,"accession":"0001544982-13-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001544982-13-000002","line_url":"/filing/0001544982-13-000002","is_derivative":false,"issuer_cik":"0001091596","issuer_name":"CYTOMEDIX INC","issuer_ticker":"CMXI","issuer_name_source":null,"issuer_url":"/issuer/0001091596","owner_cik":null,"owner_name":"Aldagen Holdings, LLC; Brooke William W; Clark B. Jefferson; Carr Kathryne","owner_display_name":"Aldagen Holdings, LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":281819.0,"shares_display":"281,819","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":155000.45,"total_display":"155,000.45","total_whole":"155,000","shares_owned_after":429404.0,"shares_owned_after_display":"429,404","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-22","filed_date":"2013-02-26","scope":"insider","n_lines":6}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001091596","name":"Nuo Therapeutics, Inc.","url":"/issuer/0001091596","role":"Ten percent owner, Other","n_filings":9,"first_seen":"2013-02-26","last_seen":"2015-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001311596","name":"Regado Biosciences Inc","url":"/issuer/0001311596","role":"Director","n_filings":1,"first_seen":"2013-08-29","last_seen":"2013-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001435388","retrieved_at":"2026-08-23T21:41:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}